Totally content free.</rant ON>Doesn't that show the complete...

Totally content free.

</rant ON>
Doesn't that show the complete inability of the market to assess and price risk. Complete motherhood statements from the "analysts" who at least admit they are out of their depth. No wonder we end up with companies with no monetisation strategy but are "on-trend" like Dubber & Nuix going boom then bust in the market - complete herd mentality. These people need to have expertise in the domain they want to research companies on, not just year 10 maths skills and the ability to draw a 2-D graph.
And the assertion that you need to be a medical professional to understand Imugene is up to shows little appreciation for the thousands of science graduates and professionals who aren't medicos but can quite easily research and comprehend articles in Nature, Science and the Lancet. I wonder if these nitwits know about Google Scholar even...why don;t then invite a uni professor or Dr Karl if they want to pass commentary o what the company IS ACTUALLY DOING?


</rant OFF>

Happy Hump day everyone!